Close
Nordic 9Nordic 9

Karolinska Development (investor - Corporate Investor)

Sweden karolinskadevelopment.com
See something wrong or missing? Let us know
Offices:Stockholm

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.

Average round investment:6.63M USD
Average number per year:2.1
Distribution: 2025 (1)2024 (3)2023 (4)2022 (3)2021 (1) See the entire list
Portfolio companies: Sweden FenoMark DiagnosticsSweden Umecrine CognitionSweden AAX Biotech See the entire list
Mostly invests in: Sweden Sweden (18) Health services (23)
See the entire list

Showing 3 of 23 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Karolinska Development mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Karolinska Development

Name Criteria
United States Initialized Capital
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Biotech, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden, Denmark
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Sweden Sebastian Knutsson
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Estonia AS Amalfi
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Finland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain Werfen
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway Sarsia Seed Management
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Biotech, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden, Finland
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Belgium Amavi Capital
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden, Finland
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Germany Volksbanken Raiffeisenbanken
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Manufacturing, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Finland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Spain Repsol
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Finland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Germany EnPulse Ventures
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Sweden Novax
91%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Health services, Pharma, Manufacturing, Biotech, Software Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Top